About Yifan

Home > About Us > About Yifan

Yifan Pharmaceutical Co., is an A share company listed at Shenzhen Stock Exchange under the security company name of Yifan Pharm and Ticker Symbol of 002019.

As a pharmaceutical company focusing on innovation, R&D, and manufacturing, Yifan has established Central R&D Center, national post-doctorate scientific research center and provincial technology center (research & development center), has acquired a number of high-tech enterprises, employs over one hundred professionals with pharmacology related masters or doctorate degrees, owns two leading edge technologies (DiKineTM and ITabTM ), holds over 90 international and domestic patents.

Yifan participates the National “Tenth Five-Year Plan” Key Projects, National High Tech Industrialization Demonstration Projects and National Torch Projects; has received both the second prize of National Invention and National Technology Progress.

Yifan leverages its expertise, specialization and product portfolio in target therapeutic areas as guidance, continuously innovating, transformatively upgrading, focusing on biologics, high-end small molecule drug, special Traditional Chinese Medicine, and other key therapeutic areas. Research pipeline includes tens of small molecule drugs, ten of which are at clinical or ANDA application stages, holds over 400 approval numbers for marketing of drugs in therapeutic areas of gynecology, pediatrics, dermatology, etc. 40 of these drugs are exclusive to the company, and 20 of which are covered by national health insurance. Several biological drugs are in global phase II and III studies. Yifan is the first Chinese pharmaceutical enterprise that has innovative biological drugs in US phase II and phase III studies, bringing Chinese biologics to knock on America’s door.

Yifan has already formed manufacturing center for high-end small molecules and plant based medicines in Anhui Province, manufacturing center for dermatological and gynecological products in Sichuan Province, manufacturing center for orthopedics drug and infusion in Liaoning Province, R&D and manufacturing centers for biologics in Beijing and Shanghai and API manufacturing center in Zhejiang.

Besides Hong Kong, Macau and Taiwan, Yifan’s pharmaceutical business covers more than 60% of class II and III hospitals in all provinces and cities in China. As one of the largest manufacturer and supplier of calcium pantothenate, sales network of API covers Europe, US, and other global regions, and takes 40% -45% of global market share.

Yifan will constantly focus on pharmaceutical and healthcare industry, adhere to the development strategy of “integration, innovation, and globalization”, believe the core value of “pragmatism, innovation, honesty, and diligence”, commit ourselves to deliver benefit to customer, create development platform for employee, achieve return for shareholders, create value for society, and continue to grow as the expert of global pharmaceutical and healthcare industry.